100%(3)100% au considerat acest document util (3 voturi)
3K vizualizări2 pagini
Felodipine is A dihydropyridinederivative calcium channel blocker. It prevents entry of calcium ions into vascular smooth muscle and cardiac cells. Elderly patients: 2. Mg P.O. Daily; adjust dosage as for adults.
Felodipine is A dihydropyridinederivative calcium channel blocker. It prevents entry of calcium ions into vascular smooth muscle and cardiac cells. Elderly patients: 2. Mg P.O. Daily; adjust dosage as for adults.
Drepturi de autor:
Attribution Non-Commercial (BY-NC)
Formate disponibile
Descărcați ca DOC, PDF, TXT sau citiți online pe Scribd
Felodipine is A dihydropyridinederivative calcium channel blocker. It prevents entry of calcium ions into vascular smooth muscle and cardiac cells. Elderly patients: 2. Mg P.O. Daily; adjust dosage as for adults.
Drepturi de autor:
Attribution Non-Commercial (BY-NC)
Formate disponibile
Descărcați ca DOC, PDF, TXT sau citiți online pe Scribd
Indication: Hypertension Drug Classification: antihypertensive (Calcium antagonist) Mechanism of Action: Unknown. A dihydropyridine- derivative calcium channel blocker that prevents entry of calcium ions into vascular smooth muscle and cardiac cells; shows some selectivity for smooth muscle compared with cardiac muscle. Dosage: Adults: initially, 5mg P.O. daily. Usual dose is 2.5 to 10 mg daily; maximum recommended dosage is 10 mg. Elderly patients: 2.5 mg P.O. daily; adjust dosage as for adults. Maximum recommended dosage is 10 mg daily. Special Precaution: May precipitate significant hypotension and syncope, which may lead to reflex tachycardia and result to angina pectoris. Pregnancy Risk Category: C Adverse Rea ction: Peripheraledema and headache Contraindications: contraindicated in patients hypersensitive to drug. Form: Tablets (extended release): 2.5 mg, 5 mg, 10 mg Nursing Responsibility: Use cautiously in patients with heart failure, particularly those receiving beta blockers, and in patients with impaired hepatic function. Monitor blood pressure for response Monitor patient for peripheral edema, which appears to be both dose – and age – related. It is more common in patients taking higher doses, especially those older than age 60.